Mounjaro's Heart Pounding Approval: A Double Edged Sword for Diabetics and Weight Loss Patients The FDA's approval of Mounjaro to lower the risk of heart events in people with diabetes has sent shockwaves through the medical community.
On one hand, this is a significant breakthrough for those struggling to manage their blood sugar levels and mitigate cardiovascular risks. However, the implications are far more complex than they initially seem.
The approval raises questions about whether medications like Mounjaro can address underlying causes of insulin resistance or if they merely treat symptoms.